BetterLife Pharma (BETRF) Total Liabilities (2011 - 2026)

BetterLife Pharma has reported Total Liabilities for 16 years, with the latest figure at $4.9 million in Q2 2026.

• On a quarterly basis, Total Liabilities rose 9.75% year-over-year to $4.9 million in Q2 2026; TTM through Apr 2026 was $4.9 million, a 9.75% increase from a year earlier, with the FY2026 full-year figure at $4.8 million, down 12.57% from the prior year.
• Total Liabilities was $4.9 million for Q2 2026 at BetterLife Pharma, up from $4.8 million in the prior quarter.
• The five-year high for Total Liabilities was $6.3 million in Q2 2024, with the low at $4.0 million in Q1 2022.
• Average Total Liabilities over 5 years is $5.2 million, with a median of $5.3 million recorded in 2023.
• The sharpest annual moves came in 2022 and 2025: Total Liabilities surged 72.44% in 2022, then declined 29.76% in 2025.
• Over 5 years, Total Liabilities stood at $5.2 million in 2022, then climbed by 2.04% to $5.3 million in 2023, then decreased by 4.44% to $5.1 million in 2024, then retreated by 13.2% to $4.4 million in 2025, then grew by 10.8% to $4.9 million in 2026.
• The last three Total Liabilities figures came in at $4.9 million (Q2 2026), $4.8 million (Q1 2026), and $4.4 million (Q3 2025), per Business Quant data.